TITLE

Value of immunofixation on serum in light-chain myeloma

AUTHOR(S)
Anand, Mona; Singh, Sarika; Kumar, Rajive; Sharma, OD
PUB. DATE
November 2004
SOURCE
Annals of Clinical Biochemistry;Nov2004, Vol. 41 Issue 6, p501
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
22630848

 

Related Articles

  • The contribution of serum free light chain assay in the prognostic classification and monitoring of plasma cell disorders. KAKKAS, I. // Archives of Hellenic Medicine / Arheia Ellenikes Iatrikes; 

    In 2001 reports began to appear of a new immunoassay to measure free immunoglobulin light chains (FLC) in serum, which provides much greater sensitivity than older methods such as immunofixation. The new FLC assay has enabled the detection of monoclonal protein that was previously undetectable...

  • Diagnosis of monoclonal gammopathy of renal significance. Bridoux, Frank; Leung, Nelson; Hutchison, Colin A; Touchard, Guy; Sethi, Sanjeev; Fermand, Jean-Paul; Picken, Maria M; Herrera, Guillermo A; Kastritis, Efstathios; Merlini, Giampaolo; Roussel, Murielle; Fervenza, Fernando C; Dispenzieri, Angela; Kyle, Robert A; Nasr, Samih H // Kidney International;Apr2015, Vol. 87 Issue 4, p698 

    Monoclonal gammopathy of renal significance (MGRS) regroups all renal disorders caused by a monoclonal immunoglobulin (MIg) secreted by a nonmalignant B-cell clone. By definition, patients with MGRS do not meet the criteria for overt multiple myeloma/B-cell proliferation, and the hematologic...

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Dispenzieri, A.; Kyle, R.; Merlini, G.; Miguel, J. S.; Ludwig, H.; Hajek, R.; Palumbo, A.; Jagannath, S.; Blade, J.; Lonial, S.; Dimopoulos, M.; Comenzo, R.; Einsele, H.; Barlogie, B.; Anderson, K.; Gertz, M.; Harousseau, J. L.; Attal, M.; Tosi, P.; Sonneveld, P. // Leukemia (08876924);Feb2009, Vol. 23 Issue 2, p215 

    The serum immunoglobulin-free light chain (FLC) assay measures levels of free κ and λ immunoglobulin light chains. There are three major indications for the FLC assay in the evaluation and management of multiple myeloma and related plasma cell disorders (PCD). In the context of screening,...

  • Monoclonal Gammopathy--Associated Proliferative Glomerulonephritis. Sethi, Sanjeev; Rajkumar, S. Vincent // Mayo Clinic Proceedings;Nov2013, Vol. 88 Issue 11, p1284 

    Monoclonal gammopathy is characterized by circulating monoclonal immunoglobulin owing to clonal proliferation of immunoglobulin-producing B lymphocytes or plasma cells. Clonal proliferation of B lymphocytes is seen in B-cell lymphoma/leukemia, and clonal plasma cell proliferation is seen in...

  • Protein Electrophoresis and Immunofixation for the Diagnosis of Monoclonal Gammopathies. Rajkumar, S. Vincent; Kyle, Robert A. // JAMA: Journal of the American Medical Association;11/26/2014, Vol. 312 Issue 20, p2160 

    The article reviews the application of urine protein electrophoresis and serum immunofixation in the case of a woman in her 70s who was diagnosed with monoclonal gammopathy of undetermined significance (MGUS). Data provided shows the patient's laboratory values and describes the characteristics...

  • Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays. Katzmann, Jerry A.; Dispenzieri, Angela; Kyle, Robert A.; Snyder, Melissa R.; Plevak, Matthew F.; Larson, Dirk R.; Abraham, Roshini S.; Lust, John A.; Melton III, L. Joseph; Rajkumar, S. Vincent // Mayo Clinic Proceedings;Dec2006, Vol. 81 Issue 12, p1575 

    OBJECTIVE: To determine the relative diagnostic contribution of urine assays as part of the screening algorithm for monoclonal gammopathies. PATIENTS AND METHODS: We Identified 428 patients with a monoclonal gammopathy and monoclonal urinary protein at initial diagnosis of plasma cell dyscrasia...

  • Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey. Landgren, O; Graubard, B I; Katzmann, J A; Kyle, R A; Ahmadizadeh, I; Clark, R; Kumar, S K; Dispenzieri, A; Greenberg, A J; Therneau, T M; Melton, L J; Caporaso, N; Korde, N; Roschewski, M; Costello, R; McQuillan, G M; Rajkumar, S V // Leukemia (08876924);Jul2014, Vol. 28 Issue 7, p1537 

    Multiple myeloma (MM) incidence is markedly higher in blacks compared with whites, which may be related to a higher prevalence of monoclonal gammopathy of undetermined significance (MGUS). Our objective was to define the prevalence and risk factors of MGUS in a large cohort representative of the...

  • Serum-free light-chain assay: clinical utility and limitations. Bhole, Malini V; Sadler, Ross; Ramasamy, Karthik // Annals of Clinical Biochemistry;Sep2014, Vol. 51 Issue 5, p528 

    In the last decade, the introduction of the serum-free light-chain (sFLC) assay has been an important advance in the diagnosis and management of plasma cell dyscrasias, particularly monoclonal light-chain diseases. The immunoassay was developed to detect free light chains in serum by using...

  • Monitoring Residual Myeloma: High-Resolution Serum/Urine Electrophoresis or Marrow Biopsy With Immunohistochemical Analysis? Amanda D. Tatsas // American Journal of Clinical Pathology;Jul2010, Vol. 134 Issue 1, p139 

    Numerous methods exist for monitoring residual disease in multiple myeloma using peripheral blood, urine, and bone marrow (BM) techniques. This study was conducted in a cohort of 83 patients to compare residual disease detection using serum protein electrophoresis (SPE) and urine protein...

  • Evaluating the clonal hierarchy in light-chain multiple myeloma: implications against the myeloma stem cell hypothesis. Pfeifer, S.; Perez-Andres, M.; Ludwig, H.; Sahota, S. S.; Zojer, N. // Leukemia (08876924);Jul2011, Vol. 25 Issue 7, p1213 

    A letter to the editor is presented regarding clonal hierarchy in light-chain multiple myeloma (MM) and its implication in myeloma stem cell (MSC) studies.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics